{{Rsnum
|rsid=10234749
|Chromosome=7
|position=152690784
|Orientation=plus
|GMAF=0.2626
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 56.6 | 34.5 | 8.8
| HCB | 35.0 | 49.6 | 15.3
| JPT | 46.0 | 39.8 | 14.2
| YRI | 71.4 | 25.9 | 2.7
| ASW | 54.4 | 40.4 | 5.3
| CHB | 35.0 | 49.6 | 15.3
| CHD | 38.5 | 46.8 | 14.7
| GIH | 69.3 | 28.7 | 2.0
| LWK | 77.8 | 21.3 | 0.9
| MEX | 39.7 | 50.0 | 10.3
| MKK | 66.0 | 30.1 | 3.8
| TSI | 62.7 | 29.4 | 7.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23362303
  |Trait=Palmitic acid (16:0) plasma levels
  |Title=Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
  |RiskAllele=T
  |Pval=4E-6
  |OR=.18
  |ORtxt=unit decrease
  |OA=1
}}

{{PMID Auto
|PMID=17557904
|Title=Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.
}}

{{on chip | Illumina Human 1M}}